1. A growth factor for Mycobacterium johnei has been isolated from Mycobacterium tuberculosi as an iron complex; it has been named ferric mycobactin T. 2. Ferric mycobactin T as isolated is a mixture of at least four closely related components differing only in their fatty acid side chains. 3. Mycobactin T resembles mycobactin P in structure but differs in the following respects: (a) the aromatic acid residue is salicylic acid in place of 2-hydroxy-6-methylbenzoic acid; (b) the hydroxy acid residue is (+ )-f-hydroxybutyric acid in place of (-)-3-hydroxy-2-methylpentanoic acid; (c) its components have fatty acid side chains that are mostly different from the side chains of the components in mycobactin P preparations. One minor component in mycobactin T has probably a cis-octadec-2-enoyl side chain. The major side-chain components correspond to acids of chain length C18-C21 that are not n-saturated or n-A2-unsaturated acids. 4. The differences in biosynthesis between mycobactins T and P are discussed.
The first evidence that the mycobacteria contained special and characteristic growth factors was the observation by Twort & Ingram (1912) that Mycobacterium johnei, which failed to grow on laboratory media, would grow when the dried killed cells of M. tuberculo8si (human strain) were added to the medium. These workers afterwards found that other species of mycobacteria and extracts from them also acted as growth promoters for M. johnei. Francis, Macturk, Madinaveitia & Snow (1953) selected M. phlei as a convenient source of growth factor and devised a method of isolation. The structure of this factor, mycobactin P, was established (Snow, 1965) ; its most notable chemical characteristic was its ability to form very stable binary complexes with iron and with aluminium. Evidence of the biological function of other iron-chelating agents, such as the ferrichromes and the ferrioxamines, suggested that ferric mycobactin P played a similar biochemical role in M. phlei, and was probably concerned in the transfer of iron to enzymes involved in haem biosynthesis, though it stood somewhat apart from the other sideramines both chemically and in its biological specificity (Snow, 1965) . Among microorganisms of many different types, the ability to produce compounds stimulating the growth of M. johnei has been found only in the mycobacteria. M. tuberculosis is of outstanding importance within this genus and knowledge of the structure of its specific growth factor could be relevant to the chemotherapy of tuberculosis. The present paper reports the isolation and characterization of this factor, which has been named mycobactin T; its structure in general resembles that of mycobactin P, but differs from it at three points in the molecule.
RESULTS
Fractions referred to by numbers and letters correspond to those described in the Experimental section and Tables. M. tuberculo8si grown on the usual media produces very small amounts of mycobactin T. To obtain workable yields of the factor the organism was grown on a glycerol-beef-infusion medium similar to that used for growing M. phlei for mycobactin P production. This medium supported the growth of M. tuberculo8si only poorly. Recent evidence suggests that stimulation of growth-factor production may depend on the presence of a very limited supply of iron in the medium (see Snow, 1965 was not crystalline, but showed El% at 450mp, 42-1, which could not be raised by further chromatography and which slightly exceeded the E1% for crystalline ferric mycobactin P (40-9). This fact, coupled with the behaviour of the product on degradation and the properties of its derivatives, indicated that the compound was substantially free from impurities.
The absorption spectrum of ferric mycobactin T ( Fig. 1 ) differed from that of ferric mycobactin P in details at lower wavelengths.
Ferric mycobactin T, like the P compound, dissociated in strong mineral acids giving a metalfree product that had an absorption spectrum similar to that of mycobactin P but shifted to lower wavelengths (Fig. 2) . This suggested that mycobactin T resembled mycobactin P in possessing an o-hydroxyphenyloxazoline structure but with some difference in substitution. The spectrum corresponded closely to that of an equimolar mixture of 2-o-hydroxyphenyloxazoline and Nethyloctadec-2-enohydroxamic acid (cf. structural considerations for mycobactin Snow, 1954b (Lemieux & Giguere, 1951) at the ,8-carbon atom as the (-)-3-hydroxy-2-methylpentanoic acid obtained in the degradation of cobactin P (Snow, 1965) . The structure of cobactin T is thus (I).
Mycobactic acid T, a crude gum like its P analogue, was hydrolysed with boiling acid to give a mixture of amino acids and acidic ether-extractable products. The amino acids were shown by paper chromatography and electrophoresis to be serine and 2-amino-6-hydroxyaminohexanoic acid together with a little lysine, the same products as from mycobactic acid P. The ether-soluble fraction was separated into two parts by column chromatography. One part was salicylic acid; the corresponding product from mycobactic acid P was 2-hydroxy-6-methylbenzoic acid, which became decarboxylated to m-cresol under the conditions of acid hydrolysis. The second part (fraction III) ......, ethyl-tran8-octadec-2-enohydroxamic acid; ----, arithmetic sum of curves for 2-(o-hydroxyphenyl)oxazoline and ethyl-tran8-octadec-2-enohydroxamic acid; mycobactin P. All were measured as solutions in methanol.
contained a mixture of long-chain fatty acids. Fraction III was crystallized to give IIIA, still a mixture.
Previous experience with the degradation of mycobactin P had shown that acid hydrolysis brought about ci8-to-tran8 isomerization of the ac,B-double bond in the side chain, whereas oxidation with periodate gave the C68 acids without isomerization. Mycobactic acid T was therefore subjected to periodate oxidation and the fatty acid fraction isolated (fraction VI). The mixtures from both degradation procedures were compared with transand ci8-octadec-2-enoic acid, the principal products from acid hydrolysis and periodate oxidation respectively of mycobactin P.
The infrared-absorption bands (Table 1) for fractions VI and IIIA were very similar, and showed many similarities to the bands in ci8-and trans-octadec-2-enoic acid. In particular they both showed a band about 6-1,u, indicating the presence of A2-unsaturation. However, with fractions IIIA and VI this band was weak relative to the intense band given by the reference acids. This suggested that only part of the acids in the mixture had A2-unsaturation. There was also some evidence of a difference of geometrical isomers in the two mixtures: fraction VI but not fraction IIIA showed bands at 6-90 and 12-13,t, which agreed with strong bands given by the ci8 reference acid but not by the tran8 acid; fraction IIIA showed a well-marked band at 10 33,u that was very weak in fraction VI; this band is considered to be characteristic of the tran8 structure and was represented in the spectrum of tran8-octadec-2-enoic acid by a strong band at 10-20, not found with the cts isomer. The infrared evidence thus suggested that some of the side-chain acyl groups had the cis-A2-unsaturated structure and were isomerized by acid treatment, but otherwise the mixture obtained by acid hydrolysis seemed to have a very similar composition to that given by periodate oxidation. The fractions examined by infrared spectroscopy together with fraction IIIB, the residue from the mother liquors ofthe crystallization of fraction III, were converted into methyl esters, which were examined by vapour-phase chromatography ( Table 2 ). The main comparison is between fractions VI and IIIB, since the latter comprised 84% of the total product obtained by (II) . The stereochemistry of asymmetric centres, apart from the one indicated, has not been determined, but is presumably identical with that of mycobactin P (III).
DISCUSSION
The isolation and characterization of the longsought growth factor from M. tuberculo8i8 supports the view that the mycobactins form a distinct family of sideramines peculiar to the mycobacteria. Both M. tuberculo8i8 and M. phlei produce groups of closely related compounds; the two groups differ substantially from each other but are recognizably of the same chemical type. Other mycobacteria may well produce other compounds of the same general type. The potency of mycobactins P and T in promoting the growth of M. johnei is almost identical. The ferrichromes provide a parallel in the occurrence of a number of closely related sideramines of similar potency, and in this case, too, each species of micro-organism produces its own characteristic group of sideramines (Zahner, Keller-Schierlein, Hutter & De6r, 1963) . In the other two main groups of sideramines, naturally occurring competitive inhibitors ofrelated structure have been found: e.g. albomycin, related to fermchrome (Mikes, Turkov& & z orm, 1963) , and ferrimycin A1, related to the ferrioxamines (Prelog, 1964) . So far no corresponding antibiotic related to the mycobactins has been found; if such a compound were discovered it should have a specific action against mycobacteria. Mycobactin T was found in M. tubercuZosi8 as its ether-soluble iron complex. This explains the results of Marks (1954) , who found that the growth of inocula of M. tuberculosi8 on unfavourable media was stimulated both by mycobactin and by ether extracts of M. tubercUo08i8; these findings were hitherto puzzling because metal-free mycobactin P is not extractable with ether. Marks's (1954) growth factor was evidently ferric mycobactin T.
In considering the chemical divergence between mycobactins T and P, the difference in the fatty acid side chain may be compared with the differences Vol. 97 found in the aliphatic side chains of other pairs of chemically related compounds isolated from M. tubercutosi8 and from M. phlei, such as the two different members of the vitamin K group (Noll, Riiegg, Gloor, Ryser & Isler, 1960; Gale et al. 1963 ) and the two types of mycolic acid (Lederer, 1960) . Analogy with other micro-organisms suggests that the ,B-hydroxybutyric acid fragment in mycobactin T is derived from the condensation of two acetyl units. Probably, as suggested by Asselineau (1962) , the corresponding acid, 3-hydroxy-2-methylvaleric acid, from mycobactin P comes from the condensation of two propionic acid units. Salicylic acid is rarely found in micro-organisms. It has been reported in Penicillium gri8eofulvum (Simonart & Wiaux, 1959) , but otherwise only in mycobacteria. Its occurrence in M. tuberculosis (Stendal, 1934; Ratledge & Winder, 1962) therefore suggests that it may be a precursor in the biosynthesis of mycobactin T. The corresponding precursor for mycobactin P is presumably 2-hydroxy-6-methylbenzoic acid. The biosynthesis of this acid in P. urticae has been shown to involve the condensation of one acetate and three malonate units (Lynen & Tada, 1961; Birch, Cassera & Rickards, 1961; Bu'Lock, Smalley & Smith, 1962) , and this mechanism is probably common to other microorganisms. In isolated plant tissues salicylic acid has been shown to be formed from phenylalanine and from benzoic acid (Klambt, 1962; El-Basyouni, Chen, Ibrahim, Neish & Towers, 1964) . This type of biosynthesis from phenylalanine, probably involving cinnamic acid as an intermediate, does not seem to be characteristic of micro-organisms, though it cannot be excluded as a possibility. Another route to salicylic acid would be by elimination of the methyl group from 2-hydroxy-6-methylbenzoic acid. Evidence of oxidation of this methyl group, first to the aldehyde and then to the carboxylic acid, has been found in P. urticae (Bassett & Tanenbaum, 1958; Tanenbaum & Bassett, 1958) . The product, 3-hydroxyphthalic acid, is synthesized from acetate by P. inlandicum (Gatenbeck, 1958) , though evidence suggests that it is formed in this organism not from 2-hydroxy-6-methylbenzoic acid but by oxidation of islandicin (Gatenbeck, 1960 siphoned off and the residue was extracted twice more with similar volumes of ether. The final residue was dried in air (fraction D). The combined ether extract, which was sometimes turbid with very fine suspended matter, was concentrated to one-twentieth of the original volume, and the concentrate was mixed with acetone (4vol.). Some waxy material was precipitated and any suspended matter still present in the ether concentrate was carried down. The precipitate was removed by centrifuging and was washed by resuspension in acetone and dried (fraction E). The combined supernatants were evaporated to give a brown wax (fraction F). Fraction F (50g.) was dissolved in light petroleum (b.p. 40-60°) (2-51.) and repeatedly extracted with ethanol containing 30% (v/v) of water (3 x 2.51.). The lightpetroleum layer on evaporation gave a golden-brown wax (fraction G). The aqueous ethanolic extracts were combined and evaporated under reduced pressure. The residue was dissolved in light petroleum-CHCl3 (1:1, v/v) and washed with water to remove a little syrupy material and the solution was again evaporated giving a deep-red-brown pasty residue (fraction H).
Purification of ferric mycobactin T by chromatography.
The description gives weights and volumes for single columns at each stage. Separations were each carried out twice or more and the combined yields for several columns are given in Scheme 2. Stage 1. Fraction H (8g.) was.dissolved in benzene (100ml.) and applied to a column (4.5cm.x 18cm.) of alumina (Spence grade 0) (280g.) suspended in benzene, and the chromatogram was developed with benzene containing 2% (v/v) of methanol. Several bands separated; the required product was in the most prominent deep-redbrown band. The eluate emerging before this band (880ml.) on evaporation gave fraction I. The eluate containing the red-brown band (420ml.) gave fraction J and the column was then eluted with 500ml. of methanol-CHCI3 (3:2, v/v) to give fraction K.
Stage 2. Fraction J (1g.) was dissolved in benzene-CHC13 (9:1, v/v) (lOml.) and applied to a thin layer of alumina (2g.) in a sintered funnel; a dark rubbery material was left on the surface of the adsorbent. The alumina was washed with the same solvent and the combined filtrate was evaporated, giving fraction L. Alumina (acid-washed, grade 1; Woehlm, Eschwege, Germany) was suspended in benzene-CHCl3 (9:1, v/v) to give a column 0 35 cm. x 30 cm. Fraction L (270mg.) dissolved in solvent (lml.) was applied and development was continued with the same solvent; lml. fractions were collected and evaporated, and El% at 450m,u was determined for each; fractions of similar purity were combined and evaporated. Successive combined fractions and corresponding volumes of eluate were: fraction M, yellow oil (45ml.); fraction N, deep-red-brown gum (7 ml.); fraction 0, red-brown gum (8ml.); fraction P, red-brown gum (9 ml.). The column was finally washed with benzene-CHCl3-methanol mixture (7:1:2, by vol.) (40ml.) , and the eluate evaporated to give fraction Q, as a light-brown wax.
Stage 3. Another column was prepared exactly as in stage 2 except that the solvent was benzene- CHCl3 (39:1, v/v) . Fraction N (89mg.) was dissolved in the solvent (imi.) and applied to the column. Development was begun by running through 17.5 ml. of the same solvent. The front of the main red-brown band was then 2-3 cm. from the lower end of the column; the eluate on evaporation yielded fraction R as a yellow oil. Gradient elution was then started. The column was fed from a stirred cylindrical vessel containing 70 ml. of the same solvent; attached to this was a parallel cylindrical feeder vessel of half the cross-sectional area containing 35 ml. of by vol.) ; lml. fractions were collected and combined on the same principle as before; successive combined fractions came from the following volumes of eluate (some evaporation of solvent occurred during collection): fraction S, 2 ml.; fraction T, 3 ml.; fraction U, 10 ml.; fraction V, 1 lml. All gave red-brown resinous gums on evaporation. The column was washed with 15ml. of benzene-CHCl3-methanol (35:1:4, by vol.) ; this eluate on evaporation gave fraction W (red-brown gum).
Stage 4. Fraction U (41mg.) was again submitted to gradient chromatography under conditions identical with stage 3 except that the column dimensions were 0-25 cm. x 28 cm. and the volumes of the gradient solutions were 50 ml. and 25 ml. Two combined fractions X and Y were obtained, both deep-red-brown gums.
Fraction X represented the purest ferric mycobactin T that could be obtained. 42-1, 137 and 250 respectively), and the iron content was 5-8%. The full absorption spectrum is shown in Fig. 1 .
Preparation of mycobactin T from its ferric complex.
Ferric mycobactin T (48mg.) was dissolved in CHC13 (25ml.) and shaken with 5N-HCI (2x 25ml.); the CHC13 solution, now colourless, was washed repeatedly with water until the washings were not acidic, then clarified and evaporated. The residue was treated with dry ether (2-5ml.); it dissolved, but slowly a white gelatinous precipitate separated from solution. The suspension was kept for 20hr. at 00 and then centrifuged; the residue was washed twice by resuspension in cold ether and was finally dried in a vacuum desiccator, giving mycobactin T (36 mg.) as an almost white powder, m.p. 128-129.5', [oc]24_-13-1 +10 (c 2-1 in CHC13), A, , .. 242, 249 and 304m, u (El%°m 156, 153 and 56 respectively) and an inflexion at 258 m,u (full absorption spectrum in Fig. 2) . The solid showed an apple-green fluorescence in ultraviolet light.
Preparation of aluminium mycobactin T. Mycobactin T (1-26mg.) was dissolved in butanol (0-2ml.), and AlCl3 solution (0-02ml., 2% in ethanol) was added. After dilution with 0-5ml. of butanol the solution was washed with water (4 x 0 5 ml.) until the washings were not acidic. The butanol was evaporated under reduced pressure and the residue dried at 1000 in vacuo, to give aluminium mycobactin T (1.28mg.). The solid and its methanolic solutions showed an intense purple fluorescence. The ultraviolet spectrum is shown in Fig. 1 .
Scission of mycobactin T in alkaline solution. Mycobactin T (28-0 mg.) was dissolved in methanol (0-2 ml.), and N-NaOH (lml.) was added. After lhr. at 200 the solution was neutralized with N-HCI (lml.). The yellowish flocculent respectively). The aqueous layer from the ether extraction was evaporated and the residue was powdered and extracted repeatedly with boiling acetone (3 x 8ml.). The extracts were filtered and evaporated to give crude cobactin T (9-6mg.), which slowly crystallized. It was compared with cobactin P (the cobactin from mycobactin P) by thin-layer chromatography on silica-gel plates by using water for development (RF values: cobactin T, 0-42; cobactin P, 0-35), and by paper electrophoresis in aq. M-diethylamine buffer for 90min. at 3-5kv (distance of migration: cobactin T, 9-7cm.; cobactin P, 8-0cm.; in a mixture there was a clear separation of the spots). For these tests the spots were revealed by spraying with ethanolic FeCl3.
Acid hydrolysis of mycobactic acid T. Crude mycobactic acid T (21-2mg.) was refluxed for 6hr. with ; the solution was cooled and extracted with ether (3 x 4ml.). The aqueous layer was evaporated to give a pale-brownish gum (fraction I) (16-lmg.). The ether extract was washed, dried and evaporated to a crystalline solid (fraction II) (15-8mg.). Silica gel (Mallinckrodt) was ground with water (0-4ml./g.), suspended in cyclohexane saturated with water and used to prepare a column 26 cm. x 0-5 cm.
ProductIIwas dissolvedinether (0-2ml.) andthe solution was adsorbed on dry silica gel (0-2g.). After evaporation of the ether the dry solid was allowed to settle on the top of the prepared column. For gradient elution the column was fed from a stirred cylindrical vessel containing cyclohexane (BOml.); attached to this was a smaller parallel cylindrical feeder vessel containing ether-cyclohexane (1:1, v/v) (30ml.). Fractions were collected and combined to give two clearly separated products: fraction III (9-Omg.), a waxy solid, and fraction IV (2-3mg.), a white crystalline solid (A. in methanol 236 and 305m,u) that gave a violet colour with FeCl3; its infrared spectrum in a KBr disk showed it to be salicylic acid.
Product III was crystalized from light petroleum (b.p. 40-60°) at -150 and then from methanol at -10°to give a white crystalline solid (fraction IIIA) (1-5mg.), m.p. 61-5-62°; the combined mother liquors were evaporated, giving a waxy residue (fraction IIIB). The infrared spectrum offraction HIIA was recorded; fractions IIIA and IIIB were examined by vapour-phase chromatography (see below).
Acid hydrolysis of cobactin T. Crude cobactin T (9-6mg.)
was refluxed for 6hr. with 5N-HCI (lml.); the solution was cooled and extracted with ether (5 x 2ml.). The ether extract was washed with 5N-HCI (0-3ml.) and dried over MgSO4. The ether was gently evaporated and the residue distilled in a small retort (0-01mm. Hg; bath temp. 900), giving a colourless oil (approx. 2 mg.). The infrared spectrum as a liquid film was identical with that of -hydroxybutyric acid. The product recovered from spectroscopy showed
[a]2°+30+ 10°in ethanol. The aqueous solution from the original hydrolysis was evaporated to a pale-brownish gum (fraction V) (8-6mg.).
Examination of water-soluble hydrolysis products. About 50,ug. of each product, I and V, was submitted to paper chromatography with ethyl methyl ketone-propionic acidwater (15:5:6, by vol.) and to paper electrophoresis at pH2 with m-acetic acid-0-75x-formic acid and at pHS with 0-04m-acetate buffer. In each case comparison was made with lysine, serine and 2-amino-6-hydroxyaminohexanoic acid dihydrochloride, run separately and as a mixture. The separated components were detected by ninhydrin and by triphenyltetrazolium chloride and alkali (Snow, 1954a) . Results are shown in Table 3 . Oxidation of mycobactic acid T with periodate. Mycobactic acid T (7-9mg.) was dissolved in ether (0-2ml.) and 0O1N-NaOH (0-llml.) added; the ether was removed with a stream of air, leaving a turbid solution. Then 0-25ml. of 0-lM-NaIO4 was added. After lhr. at 200 the solution was acidified with 0-15ml. of 0-1N-HCl. The flocculent precipitate was extracted out with CHC13 (2 x 2ml.); the extract was washed, dried with MgSO4 and evaporated almost to dryness. Light petroleum (b.p. 40-60°) (2ml.) was added and the brown flocculent precipitate (4-3mg.) was spun down. The supernatant was evaporated to give an almost-white partly-crystalline residue (fraction VI) (3.4mg.). This product was examined by infrared spectroscopy and by vapour-phase chromatography.
Vapour-phase chromatography of long-chain fatty acid product. Each product, IIIA, IIIB and VI, was dissolved in ether (0-1ml.) 
